Waukegan, IL, United States

Abbott Laboratories

abbott.com
Waukegan, IL, United States

Abbott Laboratories is an American pharmaceuticals and health care products company. It has 90,000 employees and operates in over 130 countries. The company headquarters are in Abbott Park, North Chicago, Illinois. The company was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2010, revenues were over $35 billion.In 1985, the company developed the first HIV blood-screening test. The company's drug portfolio includes Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis; Norvir, a treatment for HIV; Depakote, an anticonvulsant drug; and Synthroid, a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassay products as well as nutritional products, including Ensure, a line of meal replacement shakes; and EAS, the largest producer of performance-based nutritional supplements.The company's in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals diagnostics information at the point of patient care. Abbott also provides point-of-care cardiac assays to the emergency room. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

Patent
Abbott Laboratories | Date: 2017-02-15

A nutritional supplement powder and method of supplementing the nutritional value of a food or beverage is provided. The nutritional supplement powder includes a protein system, vitamins, minerals, and fiber. The protein system has a water solubility of at least about 70% at room temperature. The nutritional supplement powder is essentially free of divalent ions of copper, iron, and zinc, and is also essentially free of vitamin C. When added to a food or beverage, the nutritional supplement powder does not substantially change the organoleptic properties of the food or beverage.


Patent
Abbott Laboratories | Date: 2017-01-30

The invention relates to a cartridge housing for forming a cartridge capable of measuring an analyte or property of a liquid sample. The housing including a top portion having a first substantially rigid zone and a substantially flexible zone, a bottom portion separate from the top portion including a second substantially rigid zone, and at least one sensor recess containing a sensor. The top portion and the bottom portion are bonded to form the cartridge having a conduit over at least a portion of the sensor. The invention also relates to methods for forming such cartridges and to various features of such cartridges.


Patent
Abbott Laboratories | Date: 2017-01-31

A biological fluid sample analysis cartridge is provided. The cartridge includes a housing, a fluid module, and an analysis chamber. The fluid module includes a sample acquisition port and an initial channel, and is connected to the housing. The initial channel is sized to draw fluid sample by capillary force, and is in fluid communication with the acquisition port. The initial channel is fixedly positioned relative to the acquisition port such that at least a portion of a fluid sample disposed within the acquisition port will draw into the initial channel. The analysis chamber is connected to the housing, and is in fluid communication with the initial channel.


Patent
Abbott Laboratories | Date: 2017-01-26

Systems and methods for measuring dysphotopsia are provided. These systems and methods can be used to objectively quantify positive and negative dysphotopsia. One embodiment provides a system and method for determining dysphotopsia that uses a first light source configured to provide light energy to illuminate a model eye, a refractor for refracting the light energy from the first light source and directing it into the model eye, a first electronic light sensor for measuring an amount of light in the model eye; a second light source configured to provide light energy to illuminate the model eye, wherein the light energy from the second light source is introduced at an angle from the first light source; and a second electronic light sensor for measuring the amount of light in the model eye, wherein the second electronic light sensor is capable of taking measurements from various points around the model eye. Data from these measurements can then analyzed to provide an objective measurement of dysphotopsia.


Patent
Abbott Laboratories and CAMBRIDGE ENTERPRISE Ltd | Date: 2017-01-24

A system and method for reducing the number of hypoglycemic alarms presented to a user is presented. The system and methods include use of model based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm caused by an actual hypoglycemic state with the presentation of alarms caused by artifacts in the signals produced by a continuous glucose monitor.


Patent
Abbott Laboratories | Date: 2017-01-30

A haptic is provided for use in an accommodating intraocular lens. The haptic has multiple filaments, each connected to the edge of the optic at one end. Each filament has a shape that conforms to an equatorial region of the capsular bag. The haptic couples the forces exerted by the capsular bag of the eye during accommodation radially to the edge of the optic, produce a diametric expansion or compression of the optic. This diametric motion distorts the optic, producing a change in any or all of the anterior radius, the posterior radius, and the thickness. These changes affect the power of the lens and/or location of the image. The haptic may optionally have a thin membrane joining the filaments at the optic end, and may optionally have a connecting ring that joins the filaments at the end opposite that of the optic.


The present invention relates to certain immunoreactive polypeptides, methods for aiding in the diagnosis of lung cancer in a subject and kits for performing said methods.


Patent
Abbott Laboratories | Date: 2017-09-13

An analyte monitoring system comprising a transcutaneous glucose sensor and a data processing unit capable of bidirectional communication using an encrypted communication key based on identification information of the data processing unit.


Patent
Abbott Laboratories | Date: 2017-09-13

A foot pedal with a treadle that pivots up and down to vary its pitch, and/or side to side to vary its yaw. The pivot range of motion is divided into a plurality of zones, each zone configured to correspond to a respective virtual switch. When the treadle is pivoted into one of the zones, the corresponding virtual switch is activated. The virtual switch controls an operatively coupled device such as a handpiece used in a surgical procedure.


Jarvis M.F.,Abbott Laboratories
Trends in Neurosciences | Year: 2010

Chronic pain is characterized by enhanced sensory neurotransmission that underlies increased sensitivity to noxious stimuli and the perception of non-noxious stimuli as painful. Evidence from neurophysiological and pharmacological studies demonstrates that ATP produces pain by directly enhancing neuronal excitability via the activation of specific ligand-gated ion channels, the P2X3 and P2X2/3 receptors. In addition, ATP activates CNS glial cells (e.g. microglia) in response to persistent nociceptive stimulation. This latter effect involves several distinct receptor-mediated signaling pathways linked to the P2X4, P2X7 and P2Y12 receptors. This review summarizes new data that places these purinergic signaling events in a mechanistic context that illustrates the ability of ATP to initiate and maintain states of heightened sensory neuron excitability associated with persistent pain. © 2009 Elsevier Ltd. All rights reserved.

Loading Abbott Laboratories collaborators
Loading Abbott Laboratories collaborators